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We aimed to clarify how the trajectories of 1-hour postload plasma glucose (PG) and 2-hour PG were diﬀerent in the development
of type 2 diabetes. Using data of repeated health checkups in Japanese workers from April 2006 to March 2016, longitudinal
changes of fasting, 1-hour, and 2-hour PG on the oral glucose tolerance test were analyzed with a linear mixed eﬀects model. Of
the 1464 nondiabetic subjects at baseline, 112 subjects progressed to type 2 diabetes during the observation period (progressors).
In progressors, 1-hour PG and 2-hour PG showed gradual increases with slopes of 1.33± 0.2 and 0.58± 0.2mg/dL/year,
respectively, followed by a steep increase by which they attained diabetes. Until immediately before the diabetes transition,
age- and sex-adjusted mean level of 2-hour PG was 149± 2.7mg/dL, 34± 2.7 (30%) higher compared to nonprogressors,
while that of 1-hour PG was 206± 4.1mg/dL, 60± 4.3mg/dL (41%) higher compared to nonprogressors. In conclusion,
diabetes transition was preceded by a mild elevation of 2-hour PG for several years or more. The elevation in 1-hour PG
was larger than that of 2-hour PG until immediately before the transition to diabetes.
1. Introduction
Postload hyperglycemia is one of the early manifestations of
impaired glucose metabolism. Conventionally, investigators
deﬁned postload hyperglycemia by 2-hour plasma glucose
(PG) on the oral glucose tolerance test (OGTT) and demon-
strated that the intervention at the stage of impaired glucose
tolerance (IGT) was eﬀective to prevent or delay the
incidence of type 2 diabetes [1–3]. However, it has been
recently reported that 1-hour PG has a superior predictive
ability to 2-hour PG in three Western cohort studies [4–6]
and in two Asian cohort studies [7, 8]. Cross-sectional
investigations have also revealed that elevated 1-hour PG
rather than 2-hour PG showed a stronger correlation with
decreased insulin secretion assessed by insulinogenic index
[4, 5, 7] or acute insulin response on the intravenous glucose
tolerance test (IVGTT) [9]. The measurement of 1-hour PG
cannot be ignored to detect the individuals with impairment
of postload glucose metabolism.
In a few studies on trajectories of postload PG in the
development of type 2 diabetes, 2-hour PG showed a gradual
linear increase for more than 10 years, followed by a rapid
deterioration before the diagnosis [10–12]. They reported
that 2-hour PG on average was regulated within the normal
range (<140mg/dL) until 2 years before the onset of diabetes
[10, 12]. They and any other investigators have not reported
the trajectory of 1-hour PG.We hypothesized that 1-hour PG
might increase earlier than 2-hour PG in those who later
developed diabetes, which made its predictive ability better.
The aim of this study, therefore, was to depict trajecto-
ries of postload PG levels during the development of type 2
diabetes, with an interest in the diﬀerence of 1-hour PG
from 2-hour PG. The optimal cutoﬀ point of 1-hour PG in
this population was also estimated.
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2. Methods
2.1. Study Subjects. A historical cohort study was conducted
using data from the medical checkups of public school
employees collected in the Hokuriku Central Hospital [7].
During April 2006 and March 2010 (baseline period),
2340 employees underwent an OGTT at a checkup [13]. If
employees received more than one checkup during the
baseline period, the initial checkup data were used. After
those who had fasting PG≥ 126mg/dL and/or 2-hour
PG≥ 200mg/dL (n = 85), who had HbA1c values ≥6.9%
(52mmol/mol) (n = 42), who had undergone gastrectomy
(n = 32), who were taking steroids (n = 1), who were taking
anticancer drugs (n = 1), orwhohad anymissing data (n = 18)
were excluded, we selected 2161 nondiabetic individuals. Of
the 2161 thus selected, 1464 individuals repeated checkups
at least once by March 2016 and comprised our study sam-
ple (Figure 1). The subjects were followed until they devel-
oped diabetes; if they remained free of diabetes, follow-up
ended at the time of the last checkup. The remaining 697
subjects did not repeat checkups, which meant a follow-
up rate of 67.7%. An OGTT was performed at all checkups
during the follow-up period; but in the last two years (from
April 2014 to March 2016), an OGTT was performed on
1191 subjects and the measurement of fasting PG only
was performed in the remaining 273 subjects due to the
ﬁnancial reason of the mutual aid association. Information
on smoking and drinking habits and medical history was
obtained through a questionnaire. Subjects were considered
current smokers if they smoked at least one cigarette per
day. Alcohol use was deﬁned by the number of days per
week for drinking regardless of the amount consumed.
Signed informed consent was obtained from all subjects,
and the hospital review board approved the study protocol.
The study was registered on the University Hospital Medical
Information Network Clinical Trials Registry (UMIN-CTR,
UMIN ID: UMIN000017662).
2.2. Diagnosis of Diabetes and Blood Sampling. Diabetes was
diagnosed if fasting PG≥ 126mg/dL, 2-hour PG≥ 200mg/
dL, and/or receiving treatments for type 2 diabetes based on
the World Health Organization criteria (WHO) [14]. All
the evaluations were performed at the health check depart-
ment of the Hokuriku Central Hospital. Subjects were asked
to visit the hospital between 8:00 a.m. and 9:00 a.m. after an
overnight fast. At the baseline visit, an OGTT (75 g dextrose
monohydrate in 250ml water) with 0, 30, 60, and 120min
sampling to determine PG and insulin levels was performed
on all subjects [13]. HbA1c assay was conducted at the central
clinical laboratory in our hospital by a high-performance liquid
chromatography (HPLC) method using ADAMS HA-8170
(ARKRAY, Kyoto). The following indices of insulin secretion
and insulin sensitivity were calculated in this study: insulino-
genic index= (Ins30− Ins0[mU/L])/(Gluc30−Gluc0[mg/dL]),
where Insy and Gluy represent values at time y min during
the OGTT [15] and homeostatic model assessment of insulin
resistance (HOMA)=Glu0(mg/dL)× Ins0(mU/L)/405 [16].
2.3. Statistical Analysis. Analyses were conducted using SPSS
software version 17.0 for Windows (SPSS Inc. Chicago,
USA). Data are presented as the mean± SD or the median
with the interquartile range for continuous variables or as a
frequency for categorical variables. Subjects were divided into
two groups, those who progressed to diabetes (progressors)
and those who did not (nonprogressors). The diﬀerences in
the baseline characteristics were tested using Student’s t-test
or Mann–Whitney U tests for continuous variables or χ2 test
for categorical values. The mixed eﬀects model was used to
estimate the trajectories of fasting PG, 1-hour PG, and 2-
hour PG [17]; this technique takes into account within-
subject correlations from repeated measurements with
unequal numbers of observations per subjects and unequal
intervals between measurements. As ﬁxed eﬀects, we entered
time with sex and age as covariates into the model. We set a
timeline with 0 year at the year of diagnosis for progressors or
2,340 received oral glucose tolerance tests at checkups at baseline
(April 2006 to March 2010)
179 excluded
2,161 individuals without diabetes at baseline
697 excluded 
Who did not repeat checkups by March 2016
HbA1c ≥6.9% (n = 42)
Postgastrectomy state (n = 32)
Talking steroids (n = 1) or anticancer drugs (n = 1)
Missing clinical information (n = 18)
Fasting plasma glucose ≥126 mg/dL
and/or 2-hour plasma glucose ≥200 mg/dL (n = 85)
1,464 formed the study sample (follow-up rate was 67.7%)
Figure 1: Study sample.
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at the last checkup for nonprogressors, and time of prior
measurements was coded backward, giving minus values.
As a random eﬀect, we included the participant’s identiﬁca-
tion number. We used SPSS to calculate the annual estimated
levels of PG and used R to ﬁt the model explaining the PG
trajectories. The diﬀerence of the slopes of increase by time
between progressors and nonprogressors was examined by
the interaction between a dummy variable for progression
(0=nonprogressors; 1 =progressors) and time in the model.
Finally, to identify the optimal cutoﬀ point for progression
of type 2 diabetes, subjects were divided by their baseline data
at 140mg/dL of 2-hour PG based on the cutoﬀ value for IGT
[14], at 155mg/dL of 1-hour PG based on the prior study by
Abdul-Ghani et al. [18], and at 180mg/dL of 1-hour PG
based on the committee report of Japan Diabetes Society
[19]. Then the hazard ratio (HR) of the development of dia-
betes of those over versus those below the cutoﬀ point was
calculated by Cox proportional hazard regression analysis.
The HR was calculated using three models: Model 1, the
multivariable-adjusted model, with covariates including age,
sex, BMI, fasting PG, HbA1c, smoking status (three-level
variable: current/former/never smoker), alcohol use (three-
level variable: drinking everyday/drinking 1–6 days per
week/drinking less than 1 day per week), taking antihyper-
tensive drugs (yes or no), and taking lipid-lowering drugs
(yes or no); Model 2, in which Model 1 was additionally
adjusted for the other PG values (i.e., 2-hour PG value for
the division by 1-hour PG and 1-hour PG value for the
division by 2-hour PG); and Model 3, in which Model 2
was further adjusted for insulinogenic index and HOMA
index. A p value <0.05 was considered statistically signiﬁcant.
3. Results
3.1. Characteristics of Subjects. The study subjects were com-
posed of 1464 subjects with a mean age of 52.0± 7.0 years and
a mean BMI of 23.9± 3.2 kg/m2 at baseline. Of these, 112
subjects developed type 2 diabetes during the observation,
diagnosed by fasting PG≥ 126mg/dL (n = 51), 2-hour
PG≥ 200mg/dL (n = 72), and/or receiving treatments for
type 2 diabetes (n = 2). The remaining 1352 subjects stayed
free of diabetes until follow-up. Table 1 presents the baseline
characteristics of the two study groups: progressors and
nonprogressors. Progressors included a higher proportion
of men and had higher BMI, higher PG and insulin concen-
trations during OGTT, higher HbA1c, higher HOMA index,
and lower insulinogenic index compared with nonprogres-
sors (p < 0 05). Because 75 subjects had insulinogenic index
values ≤0, the analysis including insulinogenic index was
performed on 1389 subjects.
3.2. Mixed Eﬀects Model Analysis. A mixed eﬀects model was
used as this enables eﬀective use of repeated measurements
even when numbers and intervals of observations were
diﬀerent per subjects. The number of observations in each
year was shown at the bottom of Figure 2. Fasting PG in
nonprogressors showed a slight increase from 95± 0.5mg/
dL to 98± 0.2mg/dL during the 9 years of observation. In
progressors, fasting PG showed a gradual increase until >1
year, followed by a steep increase immediately before the
diagnosis (from 112± 2.6 to 124± 1.7mg/dL) (Figure 2(a)).
A steep increase immediately before the diagnosis in pro-
gressors was also observed for 1-hour PG (from 220± 5.4
to 249± 3.9mg/dL) (Figure 2(b)) and for 2-hour PG (from
155± 5.4 to 221± 3.9mg/dL) (Figure 2(c)). Compared to >9
years, the estimated level was not signiﬁcantly diﬀerent in
any other year but 0 year for 1-hour PG (p < 0 01) and for
2-hour PG (p < 0 001). Age- and sex-adjusted mean level of
1-hour PG until >1 year was 206± 4.1mg/dL, 60± 4.3mg/
dL (41%) higher compared to nonprogressors (p < 0 001),
and that of 2-hour PG was 149± 2.7mg/dL, 34± 2.7mg/dL
(30%) higher compared to nonprogressors (p < 0 001). In
112 progressors, between the ﬁnal and preﬁnal measure-
ments of glucose concentrations, 42 (38.5%) had a 1-year
interval, 31 (28.4%) had a 2-year interval, and the remaining
39 (33.1%) had a 3 years or more interval, with a median
value being 2 years in all progressors. When mixed eﬀects
model analysis was conducted in 28 progressors whose
annual consecutive data were available until the diagnosis
of diabetes, steep increases in 1-hour PG and 2-hour PG were
also demonstrated (Supplementary Figure available online at
https://doi.org/10.1155/2017/5307523).
To test this statistically, we ﬁt a model including time as a
continuous variable plus a dummy variable for 0 year (1= 0
year; 0 = from −9 to −1 year). The model including this
dummy variable (piecewise model) ﬁts better than the model
with only continuous time variable (linear model) as assessed
by Akaike information criterion (AIC). As shown in Table 2,
Table 1: Baseline characteristics of the subjects.
Nonprogressors Progressors
n 1352 112
Age (years) 52± 7 53± 7
Sex (% male) 69 79∗
Body mass index (kg/m2) 23.8± 3.1 25.2± 3.7∗
Fasting plasma glucose (mg/dL) 95± 7 108± 9∗
30 min plasma glucose (mg/dL) 149± 29 185± 29∗
1-hour plasma glucose (mg/dL) 144± 41 209± 32∗
2-hour plasma glucose (mg/dL) 113± 25 148± 31∗
Fasting insulin (mU/L) 2.8/3.8/5.1 2.9/4.3/7.2∗
30 min insulin (mU/L) 19.2/28.6/45.2 12.5/22.7/35.3∗




HOMA index 0.66/0.90/1.26 0.80/1.11/1.98∗
Current smokers (%) 19.9 26.8∗







Data are expressed as mean ± SD, 25/50/75th percentile value, or number
(%). ∗p < 0 05. HOMA: homeostasis model assessment of insulin resistance.
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Time until end of follow-up (years) ‒9 ‒8 ‒7 ‒6 ‒5 ‒4 ‒3 ‒2 ‒1 0
Progressors (n) 4 8 10 23 36 33 40 51 42 112
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Figure 2: Trajectories of fasting (a), 1-hour (b), and 2-hour (c) plasma glucose until the incidence of type 2 diabetes in 112 progressors
compared to 1352 nonprogressors. Analyses were adjusted for age and sex in mixed eﬀects models. Error bars show 95% conﬁdence
intervals for the estimated levels.
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large regression coeﬃcients for progression (49.9 for 1-hour
PG and 29.0 for 2-hour PG) indicated the diﬀerence
between progressors and nonprogressors throughout the
observation. The interaction term progression× 0 year but
not progression× time was signiﬁcant both for 1-hour and
2-hour PG, indicating that the slope of increase was not sig-
niﬁcantly diﬀerent between progressors and nonprogressors
until >1 year. When diabetes was deﬁned only by fasting
PG≥ 126mg/dL and/or receiving treatments for type 2 dia-
betes; that is, individuals with isolated postload hyperglyce-
mia were excluded from progressors, the results were
similar (data not shown).
3.3. Predictive Abilities of Diﬀerent Cutoﬀ Points for 1-Hour
PG and 2-Hour PG. Table 3 shows the HR for the develop-
ment of diabetes of those over versus those below the three
diﬀerent cutoﬀ points. The HR of those with 1-hour
PG≥ 155mg/dL versus 1-hour PG< 155mg/dL and the
HR of those with 1-hour PG≥ 180mg/dL versus 1-hour
PG< 180mg/dL were signiﬁcantly elevated even after
adjusted for 2-hour PG, insulinogenic index, and HOMA
index. The elevated HR of those with 2-hour PG≥ 140mg/
dL versus 2-hour PG< 140mg/dL was signiﬁcant (p < 0 05)
but was attenuated after further adjustments for 1-hour PG.
4. Discussion
In this study, we depicted trajectories of postload plasma glu-
coses during the development of type 2 diabetes in Japanese
workers. In agreement with prior studies [10–12], diabetes
transition was preceded by a mild elevation of 2-hour PG
for many years where the slopes of increase were not signiﬁ-
cantly diﬀerent between progressors and nonprogressors.
The diﬀerence between progressors and nonprogressors
was relatively large in 1-hour PG rather than 2-hour PG until
immediately before the diagnosis. These trajectories help to
understand why 1-hour PG better predicts the future devel-
opment of type 2 diabetes than 2-hour PG.
A rapid glucose rise in 2-hour PG immediately before the
onset of diabetes (from −1 to 0 year) conﬁrmed in this study
was consistent with several cohort studies [10–12, 20, 21]. In
the Pima longitudinal study which comprised 20 years before
the development of diabetes, an exponential increase in the
2-hour glucose levels occurred during the ﬁnal 4 years pre-
ceding the onset [10]. Ferrannini et al. also reported that
the natural history of diabetes was marked by a steep increase
in 2-hour plasma glucose in 3 years or shorter time frame, in
which they discussed instability paradigm, in individuals
who are destined to become diabetic; insulin sensitivity
and insulin secretion are more or less altered, generating
a critical state of instability [11]. In such an unstable
condition, a relatively small further change would result
in a large, rapid rise in glucose concentrations. In the
Whitehall II Study, the magnitude of this rapid increase
in 2-hour PG was larger than 70mg/dL from >2 to 0 year
[12], which was comparable to ours (68mg/dL from >1 to
0 year). As diabetes was attained by such a rapid rise in
the short time frame, the diﬀerence of 2-hour PG between
progressors and nonprogressors does not become large
until just before the diagnosis.
Table 2: Fixed eﬀects in the mixed eﬀects models for changes of fasting, 1-hour, and 2-hour plasma glucose values in 112 progressors
compared to 1352 nonprogressors.
Fasting PG (mg/dL) 1-hour PG (mg/dL) 2-hour PG (mg/dL)
Regression coeﬃcient SE Regression coeﬃcient SE Regression coeﬃcient SE
Intercept 89.9 0.9 105.2 4.2 101.6 2.7
Time (per year) 0.22 0.0 1.33 0.2 0.58 0.2
Progression — — 49.9 7.9 29.0 5.7
Progression× time 1.23 0.2 — — — —
Progression× year 0 10.1 1.1 28.3 4.9 67.6 3.9
Piecewise mixed eﬀects modeling adjusted for age and sex. Time = a continuous variable set at the year of diagnosis for progressors or at the last checkup for
nonprogressors with 0; progression = a dummy variable, 1 for progressors and 0 for nonprogressors; all coeﬃcients are signiﬁcant, p < 0 001.
Table 3: Hazard ratios (HR) for the development of diabetes by diﬀerent cutoﬀ points of 1-hour PG and 2-hour PG.
Cutoﬀ point Sensitivity (%) Speciﬁcity (%) Crude HR (95% CI)
Adjusted HR (95% CI)
Model 1 Model 2 Model 3
1-hour PG ≥155mg/dL (8.6mmol/L)
(yes versus no)
92.9 60.3 18.2 (8.9–37.4) 7.7 (3.6–16.3) 5.9 (2.7–12.7) 5.1 (2.2–11.8)
1-hour PG ≥180mg/dL (10.0mmol/L)
(yes versus no)
83.0 78.3 15.9 (9.7–26.0) 6.8 (3.9–11.9) 5.2 (2.9–9.4) 4.3 (2.3–8.1)
2-hour PG ≥140mg/dL (7.8mmol/L)
(yes versus no)
60.7 83.4 7.3 (5.0–10.8) 3.1 (2.0–4.8) 1.6 (1.0–2.6) 1.6 (1.0–2.6)
Model 1: adjusted for age, sex, body mass index, fasting PG, HbA1c, smoking status, alcohol use, taking antihypertensive drugs, and taking lipid-lowering drugs.
Model 2: adjusted for Model 1 variables plus the other PG (i.e., 2-hour PG for cutoﬀ of 1-hour PG and 1-hour PG for cutoﬀ of 2-hour PG). Model 3: adjusted for
Model 2 variables plus insulinogenic index and HOMA index.
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Mild elevation in 2-hour PG levels continued for sev-
eral years or more until just before the aforementioned
rapid rise. During this period, the slope in 2-hour PG as
well as 1-hour PG was not signiﬁcantly diﬀerent between
progressors and nonprogressors, in agreement with the
results from the Whitehall II Study [12]. Therefore, con-
trary to our hypothesis, 1-hour PG did not increase earlier
or faster than 2-hour PG, but the diﬀerence between progres-
sors and nonprogressors present at the commencement of
the observation was maintained for many years. As the diﬀer-
ence in 1-hour PG was relatively larger rather than 2-hour
PG until immediately before the diagnosis, it would be natu-
ral that progressors and nonprogressors were better discrim-
inated by 1-hour PG than 2-hour PG.
Higher 1-hour PG than 2-hour PG is common in nondi-
abetic people as demonstrated by the studies on the shape of
glucose curve during the OGTT [22–24]; about half of the
study subjects had monophasic glucose curves, with a peak
during 30–90min followed by a decrease during 90–
120min. The second popular type was biphasic, who had a
nadir by 90min and an increase again during 90–120min.
Compared to subjects with biphasic shape, monophasic
subjects had a worse insulin sensitivity, lower insulin secre-
tion, higher 1-hour PG [22–24], and higher risk for type 2
diabetes [25]. The elevation of 1-hour PG might reﬂect the
characteristic of these monophasic type of subjects. Whether
the elevation of 1-hour PG is acquired or inherent is not
known, but elevated 1-hour PG is likely to be present in
the very early years in the natural course of the development
of type 2 diabetes.
The cutoﬀ point of 155mg/dL for 1-hour PG was ﬁrst
proposed by Abdul-Ghani et al. [18] and has been demon-
strated to be useful to identify the individuals at higher risk
for type 2 diabetes in other independent cohort studies from
Finnish [5], Jewish [8], and Asian Indian populations [26].
Abdul-Ghani et al. set 155mg/dL based on the result that
the sum of sensitivity and speciﬁcity was maximal (0.75
and 0.79 for sensitivity and speciﬁcity, resp.), and they also
reported that the optimal cutoﬀ point for fasting PG was
as low as 94mg/dL applying the same method [18]. Indeed,
the HR for future diabetes was signiﬁcantly elevated both in
NGT and IGT with 1-hour PG 155≤mg/dL in this study.
However, 44% of our study subjects had 1-hour PG
155≤mg/dL at baseline. Such a lower cutoﬀ point might
bring problems with socioeconomic costs as the new deﬁni-
tion of “prediabetes” did so [27, 28]. As Asians have greater
glycaemic excursions after taking glucose than Europeans
[29], the ethnicity may also be taken into account to set
the optimal cutoﬀ point for 1-hour PG.
The strength of our study is the longitudinal observation
of postload plasma glucoses, which allow for the comparison
between the trajectory of 1-hour and that of 2-hour PG.
However, several limitations of this study should be consid-
ered. First, data on subjects who did not receive checkups
during the follow-up period were not available. Subjects
who missed checkups might be less conscious about their
health, which biased the study subjects toward metabolically
healthy people. However, baseline characteristics including
BMI, glucose, and insulin concentrations between the
subjects who were followed and those who were missed were
not signiﬁcantly diﬀerent. Second, 60 out of 112 progressors
were diagnosed as diabetes only by 2-hour PG 200≤mg/dL
with normal fasting PG (<126mg/dL), and the estimated
value of fasting PG at the diagnosis (0 year) in progressors
was relatively low compared to the prior studies. Our results
may reﬂect more the character of isolated postload
hyperglycemia rather than combined fasting and post-
load hyperglycemia. However, when diagnosis of diabe-
tes was conducted only by fasting PG and/or receiving
treatments, the results were similar. Third, the measure-
ment of PG concentrations relied on a single OGTT,
which is known to have within-subject variability [30].
In conclusion, longitudinally observed, diabetes transi-
tion was preceded by a mild elevation of 2-hour PG for many
years. The diﬀerence in 1-hour PG between progressors and
nonprogressors was relatively large until immediately before
the diagnosis.
Conflicts of Interest
The authors declare that there are no conﬂicts of interest
associated with this manuscript.
Acknowledgments
The authors thank the subjects and the staﬀ at the Health
Check Department of Hokuriku Central Hospital, Dr. Toru
Aizawa at Aizawa Hospital for his thoughtful comments,
and Dr. Kota Suzuki at Aichi Medical University for the
advice on statistical analyses.
References
[1] W. C. Knowler, E. Barrett-Connor, S. E. Fowler et al., “Reduc-
tion in the incidence of type 2 diabetes with lifestyle interven-
tion or metformin,” The New England Journal of Medicine,
vol. 346, pp. 393–403, 2002.
[2] J. Tuomilehto, J. Lindstrom, J. G. Eriksson et al., “Prevention of
type 2 diabetes mellitus by changes in lifestyle among subjects
with impaired glucose tolerance,” The New England Journal of
Medicine, vol. 344, pp. 1343–1350, 2001.
[3] E. M. Balk, A. Earley, G. Raman, E. A. Avendano, A. G. Pittas,
and P. L. Remington, “Combined diet and physical activity
promotion programs to prevent type 2 diabetes among per-
sons at increased risk: a systematic review for the community
preventive services task force,” Annals of Internal Medicine,
vol. 163, pp. 437–451, 2015.
[4] M. A. Abdul-Ghani, K. Williams, R. A. DeFronzo, and M.
Stern, “What is the best predictor of future type 2 diabetes?,”
Diabetes Care, vol. 30, pp. 1544–1548, 2007.
[5] M. A. Abdul-Ghani, V. Lyssenko, T. Tuomi, R. A. DeFronzo,
and L. Groop, “Fasting versus postload plasma glucose con-
centration and the risk for future type 2 diabetes: results from
the Botnia Study,” Diabetes Care, vol. 32, pp. 281–286, 2009.
[6] A. Alyass, P. Almgren, M. Akerlund et al., “Modelling of
OGTT curve identiﬁes 1 h plasma glucose level as a strong pre-
dictor of incident type 2 diabetes: results from two prospective
cohorts,” Diabetologia, vol. 58, pp. 87–97, 2015.
6 Journal of Diabetes Research
[7] R. Oka, T. Aizawa, S. Miyamoto, T. Yoneda, andM. Yamagishi,
“One-hour plasma glucose as a predictor of the development of
type 2 diabetes in Japanese adults,” Diabetic Medicine, vol. 33,
pp. 1399–1405, 2016.
[8] M. Bergman, A. Chetrit, J. Roth, R. Jagannathan, M. Sevick,
and R. Dankner, “One-hour post-load plasma glucose level
during the OGTT predicts dysglycemia: observations from
the 24year follow-up of the Israel Study of glucose intolerance,
obesity and hypertension,” Diabetes Research and Clinical
Practice, vol. 120, pp. 221–228, 2016.
[9] M. A. Marini, E. Succurro, S. Frontoni et al., “Insulin sensitiv-
ity, β-cell function, and incretin eﬀect in individuals with ele-
vated 1-hour postload plasma glucose levels,” Diabetes Care,
vol. 35, pp. 868–872, 2012.
[10] C. C. Mason, R. L. Hanson, and W. C. Knowler, “Progression
to type 2 diabetes characterized by moderate then rapid glu-
cose increases,” Diabetes, vol. 56, pp. 2054–2061, 2007.
[11] E. Ferrannini, M. Nannipieri, K. Williams, C. Gonzales, S. M.
Haﬀner, and M. P. Stern, “Mode of onset of type 2 diabetes
from normal or impaired glucose tolerance,” Diabetes,
vol. 53, pp. 160–165, 2004.
[12] A. G. Tabak, M. Jokela, T. N. Akbaraly, E. J. Brunner, M.
Kivimaki, and D. R. Witte, “Trajectories of glycaemia, insu-
lin sensitivity, and insulin secretion before diagnosis of type
2 diabetes: an analysis from the Whitehall II study,” Lancet,
vol. 373, pp. 2215–2221, 2009.
[13] R. Oka, K. Yagi, M. Sakurai et al., “Insulin secretion and insulin
sensitivity on the oral glucose tolerance test (OGTT) inmiddle-
aged Japanese,” Endocrine Journal, vol. 59, pp. 55–64, 2012.
[14] World Health Organization ID, Deﬁnition and Diagnosis of
Diabetes Mellitus and Intermediate Hyperglycaemia: Report of
a WHO/IDF Consultation, World Health Organization,
Geneva, 2006.
[15] K. Kosaka, T. Kuzuya, R. Hagura, and H. Yoshinaga, “Insulin
response to oral glucose load is consistently decreased in estab-
lished non-insulin-dependent diabetes mellitus: the usefulness
of decreased early insulin response as a predictor of non-
insulin-dependent diabetes mellitus,” Diabetic Medicine,
vol. 13, no. 9, Supplement 6, pp. S109–S119, 1996.
[16] D. R. Matthews, J. P. Hosker, A. S. Rudenski, B. A. Naylor, D.
F. Treacher, and R. C. Turner, “Homeostasis model assess-
ment: insulin resistance and beta-cell function from fasting
plasma glucose and insulin concentrations in man,”Diabetolo-
gia, vol. 28, pp. 412–419, 1985.
[17] G. M. L. N. Fitzmaurice and J. H. Ware, Applied Longitudinal
Analysis, John Wiley & Sons, New York, 2011.
[18] M. A. Abdul-Ghani, T. Abdul-Ghani, N. Ali, and R. A.
DeFronzo, “One-hour plasma glucose concentration and the
metabolic syndrome identify subjects at high risk for future type
2 diabetes,”Diabetes Care, vol. 31, no. 8, pp. 1650–1655, 2008.
[19] Committee of the Japan Diabetes Society on the Diagnostic
Criteria of Diabetes Mellitus, Y. Seino, K. Nanjo et al., “Report
of the committee on the classiﬁcation and diagnostic criteria of
diabetes mellitus,” Journal of Diabetes Investigation, vol. 1,
no. 5, pp. 212–228, 2010.
[20] A. H. Xiang, C. Wang, R. K. Peters, E. Trigo, S. L. Kjos,
and T. A. Buchanan, “Coordinate changes in plasma glu-
cose and pancreatic beta-cell function in Latino women at
high risk for type 2 diabetes,” Diabetes, vol. 55, pp. 1074–
1079, 2006.
[21] E. Laspa, A. Christen, Z. Efstathiadou, D. G. Johnston, and
I. F. Godsland, “Long-term changes and variability in diabe-
tes risk factors prior to the development of impaired glucose
homeostasis,” Diabetic Medicine, vol. 24, no. 11, pp. 1269–
1278, 2007.
[22] M. Kanauchi, K. Kimura, K. Kanauchi, and Y. Saito, “Beta-cell
function and insulin sensitivity contribute to the shape of
plasma glucose curve during an oral glucose tolerance test in
non-diabetic individuals,” International Journal of Clinical
Practice, vol. 59, pp. 427–432, 2005.
[23] O. Tschritter, A. Fritsche, F. Shirkavand, F. Machicao, H.
Häring, and M. Stumvoll, “Assessing the shape of the glu-
cose curve during an oral glucose tolerance test,” Diabetes
Care, vol. 26, no. 4, pp. 1026–1033, 2003.
[24] A. Tura, U. Morbiducci, S. Sbrignadello, Y. Winhofer, G.
Pacini, and A. Kautzky-Willer, “Shape of glucose, insulin, C-
peptide curves during a 3-h oral glucose tolerance test: any
relationship with the degree of glucose tolerance?,” American
Journal of Physiology. Regulatory, Integrative and Comparative
Physiology, vol. 300, pp. R941–R948, 2011.
[25] M. A. Abdul-Ghani, V. Lyssenko, T. Tuomi, R. A. Defronzo,
and L. Groop, “The shape of plasma glucose concentration
curve during OGTT predicts future risk of type 2 diabetes,”
Diabetes/Metabolism Research and Reviews, vol. 26, pp. 280–
286, 2010.
[26] M. Priya, R. M. Anjana, F. S. Chiwanga, K. Gokulakrishnan,
M. Deepa, and V. Mohan, “1-hour venous plasma glucose
and incident prediabetes and diabetes in Asian Indians,”
Diabetes Technology & Therapeutics, vol. 15, pp. 497–502,
2013.
[27] T. M. Dall, W. Yang, P. Halder et al., “The economic burden of
elevated blood glucose levels in 2012: diagnosed and undiag-
nosed diabetes, gestational diabetes mellitus, and prediabetes,”
Diabetes Care, vol. 37, pp. 3172–3179, 2014.
[28] J. S. Yudkin and V.M.Montori, “The epidemic of pre-diabetes:
themedicine and thepolitics,”BMJ, vol. 349, article g4485, 2014.
[29] M. Kataoka, B. J. Venn, S. M.Williams, L. A. TeMorenga, I. M.
Heemels, and J. I. Mann, “Glycaemic responses to glucose and
rice in people of Chinese and European ethnicity,” Diabetic
Medicine, vol. 30, pp. e101–e107, 2013.
[30] K. M. Utzschneider, R. L. Prigeon, J. Tong et al., “Within-sub-
ject variability of measures of beta cell function derived from a
2 h OGTT: implications for research studies,” Diabetologia,
vol. 50, no. 12, pp. 2516–2525, 2007.
7Journal of Diabetes Research
